Jul 13, 2021 / 04:00PM GMT
Jeff Cohen - Ladenburg Thalmann & Co. Inc. - Analyst
Thank you for joining us. This is Jeff Cohen and Destiny Hance of Ladenburg Thalmann. Next up, we are very pleased to have Zynex. And with us today is Dan Moorhead, who is CFO of the Company. Dan, thanks for joining us, and the floor is yours.
Dan Moorhead - Zynex, Inc. - CFO
Thanks, Jeff. Thanks, everybody, for coming today. A quick housekeeping. There are forward-looking statements in the presentation. Forward-looking statements can vary from actual results, so you should review our risk factor sections in our SEC and press releases for more information.
So Zynex is the leader in electrotherapy for pain management in the United States. Our product, the NexWave, is prescription strength and lets patients get clinic-like or PT-like treatments from their office or their home on a 24/7 basis rather than just on doctor's visits.
We are currently building a sizable direct sales force in the US. We had about 500 sales reps at the end of the first quarter and at the end of 2020, and that
Zynex Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript
Jul 13, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers